レポートナンバー 0000030558
ヘパリンの世界市場(2021-2025)
TechNavio
Global Heparin Market 2021-2025
発刊日
2021/08/26
言語英語
体裁PDF/120ページ
レポート概要
本レポートは、世界のヘパリン市場を分析します。
世界のヘパリン市場は、予測期間中に約6%のCAGRで推移し、2021年から2025年の間に22億9,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、凝固障害の有病率の上昇と、慢性疾患の増加です。さらに、凝固障害の有病率の増加は、市場の成長も後押しすると予想されています。
調査範囲
-
市場セグメント
➣ 製品別
◇ 低分子量ヘパリン
◇ その他
➣ 投与経路別
◇ 皮下注射
◇ 静脈内/輸液
➣ 地域別
◇ ヨーロッパ
◇ 北アメリカ
◇ アジア
◇ その他の地域
この調査は、ヘパリンを生産するための代替供給源の再導入を、今後数年間のヘパリン市場の成長を推進する主な理由の1つとして特定しています。
Technavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。
本レポートは以下の分野をカバーしています。
- ヘパリンの市場規模
- ヘパリンの市場予測
- ヘパリン市場の業界分析
Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なヘパリン市場ベンダーの詳細な分析を提供します
-
調査企業
➣ Aspen Pharmacare Holdings Ltd.
➣ Baxter International Inc.
➣ エーザイ(Eisai Co. Ltd.)
➣ Fresenius SE and Co. KGaA
➣ Hikma Pharmaceuticals Plc
➣ Laboratorios Farmaceuticos Rovi SA
➣ Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd.
➣ Pfizer Inc.
➣ Sanofi SA
➣ Viatris Inc.
また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
Technavio社について
Technavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
レポート詳細
目次
Executive Summary
Market overview
Market Landscape
Market ecosystem
Value chain analysis
Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
Market Segmentation by Product
Market segments
Comparison by Product
Low-molecular-weight heparin - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by Product
Market Segmentation by Route of administration
Market segments
Comparison by Route of administration
Subcutaneous injection - Market size and forecast 2020-2025
Intravenous/infusion - Market size and forecast 2020-2025
Market opportunity by Route of administration
Customer landscape
Customer landscape
Geographic Landscape
Geographic segmentation
Geographic comparison
Europe - Market size and forecast 2020-2025
North America - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends
Vendor Landscape
Overview
Landscape disruption
Vendor Analysis
Vendors covered
Market positioning of vendors
Aspen Pharmacare Holdings Ltd.
Baxter International Inc.
Eisai Co. Ltd.
Fresenius SE and Co. KGaA
Hikma Pharmaceuticals Plc
Laboratorios Farmaceuticos Rovi SA
Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd.
Pfizer Inc.
Sanofi SA
Viatris Inc.
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
Exhibits1: Key Finding 1
Exhibits2: Key Finding 2
Exhibits3: Key Finding 3
Exhibits4: Key Finding 5
Exhibits5: Key Finding 6
Exhibits6: Key Finding 7
Exhibits7: Key Finding 8
Exhibits8: Key Finding 9
Exhibits9: Parent market
Exhibits10: Market characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibits14: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibits15: Five forces analysis 2020 & 2025
Exhibits16: Bargaining power of buyers
Exhibits17: Bargaining power of suppliers
Exhibits18: Threat of new entrants
Exhibits19: Threat of substitutes
Exhibits20: Threat of rivalry
Exhibits21: Market condition - Five forces 2020
Exhibits22: Product - Market share 2020-2025 (%)
Exhibits23: Comparison by Product
Exhibits24: Low-molecular-weight heparin - Market size and forecast 2020-2025 ($ million)
Exhibits25: Low-molecular-weight heparin - Year-over-year growth 2020-2025 (%)
Exhibits26: Others - Market size and forecast 2020-2025 ($ million)
Exhibits27: Others - Year-over-year growth 2020-2025 (%)
Exhibits28: Market opportunity by Product
Exhibits29: Route of administration - Market share 2020-2025 (%)
Exhibits30: Comparison by Route of administration
Exhibits31: Subcutaneous injection - Market size and forecast 2020-2025 ($ million)
Exhibits32: Subcutaneous injection - Year-over-year growth 2020-2025 (%)
Exhibits33: Intravenous/infusion - Market size and forecast 2020-2025 ($ million)
Exhibits34: Intravenous/infusion - Year-over-year growth 2020-2025 (%)
Exhibits35: Market opportunity by Route of administration
Exhibits36: Customer landscape
Exhibits37: Market share by geography 2020-2025 (%)
Exhibits38: Geographic comparison
Exhibits39: Europe - Market size and forecast 2020-2025 ($ million)
Exhibits40: Europe - Year-over-year growth 2020-2025 (%)
Exhibits41: North America - Market size and forecast 2020-2025 ($ million)
Exhibits42: North America - Year-over-year growth 2020-2025 (%)
Exhibits43: Asia - Market size and forecast 2020-2025 ($ million)
Exhibits44: Asia - Year-over-year growth 2020-2025 (%)
Exhibits45: ROW - Market size and forecast 2020-2025 ($ million)
Exhibits46: ROW - Year-over-year growth 2020-2025 (%)
Exhibits47: Key leading countries
Exhibits48: Market opportunity by geography ($ million)
Exhibits49: Impact of drivers and challenges
Exhibits50: Vendor landscape
Exhibits51: Landscape disruption
Exhibits52: Industry risks
Exhibits53: Vendors covered
Exhibits54: Market positioning of vendors
Exhibits55: Aspen Pharmacare Holdings Ltd. - Overview
Exhibits56: Aspen Pharmacare Holdings Ltd. - Business segments
Exhibits57: Aspen Pharmacare Holdings Ltd. - Key offerings
Exhibits58: Aspen Pharmacare Holdings Ltd. - Key customers
Exhibits59: Aspen Pharmacare Holdings Ltd. - Segment focus
Exhibits60: Baxter International Inc. - Overview
Exhibits61: Baxter International Inc. - Business segments
Exhibits62: Baxter International Inc. - Key offerings
Exhibits63: Baxter International Inc. - Key customers
Exhibits64: Baxter International Inc. - Segment focus
Exhibits65: Eisai Co. Ltd. - Overview
Exhibits66: Eisai Co. Ltd. - Business segments
Exhibits67: Eisai Co. Ltd. - Key offerings
Exhibits68: Eisai Co. Ltd. - Key customers
Exhibits69: Eisai Co. Ltd. - Segment focus
Exhibits70: Fresenius SE and Co. KGaA - Overview
Exhibits71: Fresenius SE and Co. KGaA - Business segments
Exhibits72: Fresenius SE and Co. KGaA - Key offerings
Exhibits73: Fresenius SE and Co. KGaA - Key customers
Exhibits74: Fresenius SE and Co. KGaA - Segment focus
Exhibits75: Hikma Pharmaceuticals Plc - Overview
Exhibits76: Hikma Pharmaceuticals Plc - Business segments
Exhibits77: Hikma Pharmaceuticals Plc - Key offerings
Exhibits78: Hikma Pharmaceuticals Plc - Key customers
Exhibits79: Hikma Pharmaceuticals Plc - Segment focus
Exhibits80: Laboratorios Farmaceuticos Rovi SA - Overview
Exhibits81: Laboratorios Farmaceuticos Rovi SA - Business segments
Exhibits82: Laboratorios Farmaceuticos Rovi SA - Key offerings
Exhibits83: Laboratorios Farmaceuticos Rovi SA - Key customers
Exhibits84: Laboratorios Farmaceuticos Rovi SA - Segment focus
Exhibits85: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Overview
Exhibits86: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Product and service
Exhibits87: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Key offerings
Exhibits88: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Key customers
Exhibits89: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Segment focus
Exhibits90: Pfizer Inc. - Overview
Exhibits91: Pfizer Inc. - Business segments
Exhibits92: Pfizer Inc. - Key offerings
Exhibits93: Pfizer Inc. - Key customers
Exhibits94: Pfizer Inc. - Segment focus
Exhibits95: Sanofi SA - Overview
Exhibits96: Sanofi SA - Business segments
Exhibits97: Sanofi SA - Key offerings
Exhibits98: Sanofi SA - Key customers
Exhibits99: Sanofi SA - Segment focus
Exhibits100: Viatris Inc. - Overview
Exhibits101: Viatris Inc. - Business segments
Exhibits102: Viatris Inc. - Key offerings
Exhibits103: Viatris Inc. - Key customers
Exhibits104: Viatris Inc. - Segment focus
Exhibits105: Currency conversion rates for US$
Exhibits106: Research Methodology
Exhibits107: Validation techniques employed for market sizing
Exhibits108: Information sources
Exhibits109: List of abbreviations